MetLife (MET) Downgraded by ValuEngine

ValuEngine downgraded shares of MetLife (NYSE:MET) from a buy rating to a hold rating in a research note released on Friday morning.

A number of other research analysts also recently issued reports on MET. Wells Fargo set a $62.00 price target on MetLife and gave the company a buy rating in a report on Thursday, December 14th. Zacks Investment Research downgraded MetLife from a buy rating to a hold rating in a report on Monday, December 18th. Deutsche Bank began coverage on MetLife in a report on Tuesday, January 2nd. They issued a hold rating and a $55.00 price target on the stock. Goldman Sachs reissued a buy rating on shares of MetLife in a research report on Wednesday, January 31st. Finally, Morgan Stanley lowered their price objective on MetLife from $59.00 to $58.00 and set an equal weight rating for the company in a research report on Wednesday, February 14th. One analyst has rated the stock with a sell rating, twelve have assigned a hold rating and eight have given a buy rating to the stock. The stock presently has a consensus rating of Hold and an average target price of $56.75.

How to Become a New Pot Stock Millionaire

Shares of NYSE:MET opened at $45.55 on Friday. MetLife has a 12-month low of $43.38 and a 12-month high of $55.91. The firm has a market capitalization of $46,928.83, a PE ratio of 10.12, a P/E/G ratio of 0.74 and a beta of 1.24. The company has a current ratio of 0.15, a quick ratio of 0.15 and a debt-to-equity ratio of 0.29.

MetLife (NYSE:MET) last announced its quarterly earnings results on Tuesday, February 13th. The financial services provider reported $0.64 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.05 by ($0.41). MetLife had a net margin of 5.69% and a return on equity of 8.59%. The company had revenue of $15.79 billion during the quarter, compared to analysts’ expectations of $15.89 billion. During the same quarter in the prior year, the business posted $1.28 earnings per share. equities research analysts forecast that MetLife will post 4.91 EPS for the current year.

Several institutional investors have recently bought and sold shares of the company. First Dallas Securities Inc. acquired a new stake in MetLife during the 4th quarter worth about $111,000. Sandy Spring Bank lifted its position in MetLife by 495.2% during the 4th quarter. Sandy Spring Bank now owns 2,375 shares of the financial services provider’s stock worth $120,000 after acquiring an additional 1,976 shares during the period. Wagner Wealth Management LLC acquired a new stake in MetLife during the 4th quarter worth about $126,000. Avestar Capital LLC acquired a new stake in MetLife during the 4th quarter worth about $135,000. Finally, Valeo Financial Advisors LLC acquired a new stake in MetLife during the 3rd quarter worth about $151,000. 77.69% of the stock is owned by hedge funds and other institutional investors.

WARNING: “MetLife (MET) Downgraded by ValuEngine” was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/10/metlife-met-downgraded-by-valuengine.html.

MetLife Company Profile

MetLife, Inc, through its subsidiaries, engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply